{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T12:21:10Z","timestamp":1784290870834,"version":"3.55.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21575058"],"award-info":[{"award-number":["21575058"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81271931"],"award-info":[{"award-number":["81271931"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012149","name":"National Key Scientific Instrument and Equipment Development Projects of China","doi-asserted-by":"crossref","award":["61427807"],"award-info":[{"award-number":["61427807"]}],"id":[{"id":"10.13039\/501100012149","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Immunological Methods"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.jim.2016.08.006","type":"journal-article","created":{"date-parts":[[2016,8,29]],"date-time":"2016-08-29T13:29:32Z","timestamp":1472477372000},"page":"64-69","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Rapid quantitation of human epididymis protein 4 in human serum by amplified luminescent proximity homogeneous immunoassay (AlphaLISA)"],"prefix":"10.1016","volume":"437","author":[{"given":"Hui","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanfeng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiancai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyu","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqi","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongliang","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baihong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhua","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingsong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jim.2016.08.006_bb0005","first-page":"111","article-title":"HE4 and mesothelin: novel biomarkers of ovarian carcinoma in patients with pelvic masses","volume":"11","author":"Abdel-Azeez","year":"2010","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.jim.2016.08.006_bb0010","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s13277-009-0015-y","article-title":"HE4: a new potential early biomarker for the recurrence of ovarian cancer","volume":"31","author":"Anastasi","year":"2010","journal-title":"Tumour Biol."},{"key":"10.1016\/j.jim.2016.08.006_bb0015","doi-asserted-by":"crossref","first-page":"200s","DOI":"10.1200\/JCO.2003.01.068","article-title":"Status of tumor markers in ovarian cancer screening","volume":"21","author":"Bast","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jim.2016.08.006_bb0020","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1089\/adt.2009.9996","article-title":"AlphaLISA immunoassay platform- the \u201cno-wash\u201d high-throughput alternative to ELISA","volume":"7","author":"Bielefeld-Sevigny","year":"2009","journal-title":"Assay Drug Dev. Technol."},{"key":"10.1016\/j.jim.2016.08.006_bb0025","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ygyno.2012.11.023","article-title":"Preoperative HE4 expression in plasma predicts surgical outcome in primary ovarian cancer patients: results from the OVCAD study","volume":"128","author":"Braicu","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.jim.2016.08.006_bb0030","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ygyno.2011.01.014","article-title":"CA125 surveillance increases optimal resectability at secondary cytoreductive surgery for recurrent epithelial ovarian cancer","volume":"121","author":"Fleming","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.jim.2016.08.006_bb0035","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1007\/s13277-012-0381-8","article-title":"Role of HE4, CA72.4, and CA125 in monitoring ovarian cancer","volume":"33","author":"Granato","year":"2012","journal-title":"Tumour Biol."},{"key":"10.1016\/j.jim.2016.08.006_bb0040","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ygyno.2008.04.041","article-title":"Evaluation of biomarker panels for early stage ovarian cancer detection and monitoring for disease recurrence","volume":"110","author":"Havrilesky","year":"2008","journal-title":"Gynecol. Oncol."},{"issue":"Suppl 1","key":"10.1016\/j.jim.2016.08.006_bb0045","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.1016\/S0020-7292(06)60033-7","article-title":"Carcinoma of the ovary. FIGO 26th annual report on the results of treatment in gynecological cancer","volume":"95","author":"Heintz","year":"2006","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.jim.2016.08.006_bb0050","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ygyno.2011.02.022","article-title":"No benefit from combining HE4 and CA125 as ovarian tumor markers in a clinical setting","volume":"121","author":"Jacob","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.jim.2016.08.006_bb0055","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s10895-015-1518-0","article-title":"A magnetic nanoparticle-based time-resolved fluoroimmunoassay for determination of the cytokeratin 19 fragment in human serum","volume":"25","author":"Lin","year":"2015","journal-title":"J. Fluoresc."},{"key":"10.1016\/j.jim.2016.08.006_bb0060","doi-asserted-by":"crossref","first-page":"55229","DOI":"10.1039\/C4RA09848J","article-title":"Simultaneous determination of the cytokeratin 19 fragment and carcinoembryonic antigen in human serum by magnetic nanoparticle-based dual-label time-resolved fluoroimmunoassay","volume":"4","author":"Lin","year":"2015","journal-title":"RSC Adv."},{"key":"10.1016\/j.jim.2016.08.006_bb0065","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jviromet.2014.06.002","article-title":"A time-resolved fluoroimmunoassay for the quantitation of rabies virus nucleoprotein in the rabies vaccine","volume":"206","author":"Lin","year":"2014","journal-title":"J. Virol. Methods"},{"issue":"Suppl 1","key":"10.1016\/j.jim.2016.08.006_bb0070","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1097\/IGC.0b013e318251ccaa","article-title":"The quest for ovarian cancer screening biomarkers: are we on the right road?","volume":"22","author":"Lokshin","year":"2012","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.jim.2016.08.006_bb0075","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jim.2008.05.004","article-title":"A new homogeneous assay for high throughput serological diagnosis of brucellosis in ruminants","volume":"337","author":"McGiven","year":"2008","journal-title":"J. Immunol. Methods"},{"issue":"639","key":"10.1016\/j.jim.2016.08.006_bb0080","first-page":"e1","article-title":"Validation of serum biomarkers for detection of early-stage ovarian cancer","volume":"200","author":"Nosov","year":"2009","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.jim.2016.08.006_bb0085","first-page":"5007","article-title":"Identification by cDNA microarray of genes involved in ovarian carcinogenesis","volume":"60","author":"Ono","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.jim.2016.08.006_bb0090","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1177\/1087057106297566","article-title":"A luminescent oxygen channeling immunoassay for the determination of insulin in human plasma","volume":"12","author":"Poulsen","year":"2007","journal-title":"J. Biomol. Screen."},{"key":"10.1016\/j.jim.2016.08.006_bb0095","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ygyno.2012.11.026","article-title":"Comparison of HE4, CA125 and ROMA algorithm in women with a pelvic mass: correlation with pathological outcome","volume":"128","author":"Sandri","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.jim.2016.08.006_bb0100","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0378-1119(99)00342-X","article-title":"Comparative hybridization of an array of 21,500 ovarian cDNAs for the discovery of genes overexpressed in ovarian carcinomas","volume":"238","author":"Schummer","year":"1999","journal-title":"Gene"},{"key":"10.1016\/j.jim.2016.08.006_bb0105","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/caac.20138","article-title":"Cancer statistics, 2012","volume":"62","author":"Siegel","year":"2012","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.jim.2016.08.006_bb0110","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.cca.2012.10.058","article-title":"Detection and monitoring of ovarian cancer","volume":"415","author":"Su","year":"2013","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.jim.2016.08.006_bb0115","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1586\/erm.10.87","article-title":"Ovarian cancer biomarkers for molecular biosensors and translational medicine","volume":"10","author":"Suh","year":"2010","journal-title":"Expert. Rev. Mol. Diagn."},{"key":"10.1016\/j.jim.2016.08.006_bb0120","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1080\/15321819.2015.1106950","article-title":"The development of dual-label time-resolved fluorescence immunoassay (TRFIA) for screening of ovarian cancer based on simultaneous detection of human epididymis protein-4 and cancer antigen 125","volume":"37","author":"Sun","year":"2016","journal-title":"J. Immunoass. Immunochem."},{"key":"10.1016\/j.jim.2016.08.006_bb0125","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1177\/1087057107312778","article-title":"Development of homogeneous 384-well high-throughput screening assays for Abeta1-40 and Abeta1-42 using AlphaScreen technology","volume":"13","author":"Szekeres","year":"2008","journal-title":"J. Biomol. Screen."},{"key":"10.1016\/j.jim.2016.08.006_bb0130","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0378-1119(99)00035-9","article-title":"Monitoring gene expression profile changes in ovarian carcinomas using cDNA microarray","volume":"229","author":"Wang","year":"1999","journal-title":"Gene"},{"key":"10.1016\/j.jim.2016.08.006_bb0135","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.clinbiochem.2015.07.029","article-title":"Modification of cut-off values for HE4, CA125 and the ROMA algorithm for early-stage epithelial ovarian cancer detection: results from 1021 cases in South China","volume":"49","author":"Xu","year":"2016","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.jim.2016.08.006_bb0140","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.21906","article-title":"Detection of human epididymis protein 4 (HE4) in human serum samples using a specific monoclonal antibody-based sandwich enzyme-linked immunosorbent assay (ELISA)","author":"Zhou","year":"2015","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.jim.2016.08.006_bb0145","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1080\/15321819.2012.690358","article-title":"AlphaLISA for the determination of median levels of the free beta subunit of human chorionic gonadotropin in the serum of pregnant women","volume":"34","author":"Zou","year":"2013","journal-title":"J. Immunoass. Immunochem."}],"container-title":["Journal of Immunological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175916301612?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175916301612?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T04:11:34Z","timestamp":1589688694000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022175916301612"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":29,"alternative-id":["S0022175916301612"],"URL":"https:\/\/doi.org\/10.1016\/j.jim.2016.08.006","relation":{},"ISSN":["0022-1759"],"issn-type":[{"value":"0022-1759","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rapid quantitation of human epididymis protein 4 in human serum by amplified luminescent proximity homogeneous immunoassay (AlphaLISA)","name":"articletitle","label":"Article Title"},{"value":"Journal of Immunological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jim.2016.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}